ITRM vs VTR · rev $390.0K vs P/E 149, rev $4.92B
Iterum Therapeutics PLC (ITRM) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ITRM currently screens at market cap $38.6M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ITRM and VTR stock pages for the full models.
Not investment advice.